Global Antibiotics Market Has Positive Growth Outlook to 2023

December 19, 2018

WELLESLEY, Mass., Dec. 19, 2018 – The global antibiotics market is driven by the growing use of antibiotics in emerging markets, the increasing size of the geriatric population worldwide, and rising demand as the number of infectious diseases increases. According to a new BCC Research forecast, this market will reach $55.8 billion by 2023.

The outlook is positive, with significant growth potential for beta lactams and tetracyclines. Higher disposable incomes, increased spending on healthcare in emerging markets, and the rising number of R&D grants from government agencies are also contributing to growth of the global antibiotics market. From an estimated $38.3 billion in 2018, a 5-year compound annual growth rate of 7.8% is forecast in BCC Research’s report “Antibiotics: Global Markets to 2023.”

The antibiotics market is challenged by restraints such as low return on investment, pricing pressure from regulators, antimicrobial resistance, patent expiry and antibiotic shortages. There is pressure on antibiotic manufacturers to offer drugs that overcome antimicrobial resistance at affordable prices.   

Research Highlights

  • Beta lactams represent the largest segment in the antibiotics market, at $20.7 billion. The highest growth (8.9%) is projected to occur in the tetracyclines segment.
  • Major factors for this growth include the increasing use of antibiotics to treat acne and other skin infections, respiratory tract infections, and genital and urinary infections.
  • Forty-two antibiotics in clinical development target critical and high-priority pathogens (15 antibiotics are in Phase I trials, 12 are in Phase II, and 11 are in Phase III). Four new drug applications have been submitted.

“Antibiotic drug manufacturers should consider collaborations and partnerships with other companies or government bodies to accelerate the development of new antibiotic drugs,” the report notes. “Antibiotic drug manufacturers should also consider the adoption of 3D printing technology to reduce manufacturing costs and increase production efficiency.”

Asia-Pacific Will Have Fastest 5-Year Growth

North America accounts for $12.0 billion (31.4%) of the global antibiotics market. Western Europe is the second largest region, accounting for $10.2 billion (26.7%). Asia-Pacific is forecast to rapidly expand at a 13.8% CAGR, which is attributed to increasing incidence of air and water pollution in countries such as China and India. Africa is expected to grow at a 10.6% CAGR.

Editors/reporters requesting analyst interviews should contact Eric Surber at

Antibiotics: Global Markets to 2023( PHM209A )
Publish Date: Nov 2018    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email or visit to request access to our library of market research.